首页 » NPC43 BioVector® 人鼻咽癌细胞株 / NPC43 Human Nasopharyngeal Carcinoma Cell Line

NPC43 BioVector® 人鼻咽癌细胞株 / NPC43 Human Nasopharyngeal Carcinoma Cell Line

  • 价  格:¥99860
  • 货  号:BioVector® NPC43
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作微信:1843439339 (QQ同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

BioVector® NPC43 人鼻咽癌细胞株 / NPC43 Human Nasopharyngeal Carcinoma Cell Line

一、 背景与来源说明 / Background & Origin

NPC43 是一种来源于人鼻咽癌(Nasopharyngeal Carcinoma, NPC)患者原发肿瘤组织的永生化肿瘤细胞株。由于大多数常见鼻咽癌细胞株在体外长期传代过程中容易丢失 EB 病毒(Epstein-Barr Virus, EBV),NPC43 是少数能够稳定携带并维持 EB 病毒(EBV-positive)的患者来源鼻咽癌细胞模型之一。NPC43 细胞株广泛应用于 EBV 阳性鼻咽癌发病机制、EB 病毒潜伏感染与致癌基因表达、肿瘤免疫微环境、放化疗敏感性及靶向药物筛选的研究。

二、 细胞生物学特征 / Biological Characteristics

  • 组织来源 / Tissue Origin:人鼻咽癌原发肿瘤组织 (Human Nasopharyngeal Carcinoma)

  • 生长特性 / Growth Properties:贴壁生长,呈多角形或上皮样形态

  • 关键病毒特征 / EBV Status:EB 病毒阳性 (EBV-Positive)

  • 细胞标记物 / Cell Markers

    • 上皮细胞标志物:细胞角蛋白 (Cytokeratin, CK)

    • EBV 基因表达产品:EBNA1, LMP1, EBERs

  • 应用领域 / Applications:EBV 相关鼻咽癌病理机制研究、EBV 潜伏与激活调控、抗 EBV 靶向疗法评估及放射治疗增敏药物筛选

三、 培养条件与传代指南 / Culture & Handling Protocols

1. 完全培养基配方 / Medium Formulation

  • 基础培养基 / Basal Medium:RPMI-1640 基础培养基

  • 血清与添加剂 / Serum & Supplements

    • 10% 至 15% 胎牛血清 (FBS)

    • ROCK 抑制剂(如 Y-27632,4 至 10 uM,依建系与消化复苏需要添加)

  • 抗生素 / Antibiotics:100 U/mL 青霉素 + 100 ug/mL 链霉素

2. 培养与传代操作 / Incubation & Subculture

  • 培养环境 / Conditions:37 摄氏度,5% CO2,饱和湿度

  • 密度管理 / Confluence:保持细胞密度在 30% 到 85% 之间,避免过度汇合导致 EB 病毒脱落或细胞自发凋亡

  • 传代步骤 / Procedure

    1. 吸除旧培养基,用 PBS 洗涤一次。

    2. 加入 0.25% Trypsin-EDTA,在 37 摄氏度下孵育 2 到 4 分钟至细胞脱落。

    3. 加入含血清完全培养基终止消化并轻柔吹打均匀。

    4. 以 200 x g 离心 5 分钟,重悬后按 1:2 至 1:3 比例接种。

四、 技术指标简表 / Technical Data Summary

参数 / Parameter描述 / Specification
细胞名称 / NameNPC43
生物安全等级 / BSLBSL-2 (因含有 EB 病毒)
EBV 状态 / EBV StatusEBV 阳性 (EBV-Positive)
关键标记物 / MarkersCytokeratin, EBNA1, EBERs
生长形态 / Morphology贴壁生长,上皮样细胞
主要应用 / Key UsesEBV 阳性鼻咽癌发病机制、EBV 靶向治疗、放化疗敏感性实验

BioVector® NPC43 Human Nasopharyngeal Carcinoma Cell Line

1. Background and Origin

NPC43 is a patient-derived cell line established from human nasopharyngeal carcinoma (NPC) tissue. Unlike many classical NPC lines that tend to lose the Epstein-Barr virus (EBV) during prolonged in vitro passage, NPC43 is one of the rare cell models that stably retains the EBV genome (EBV-positive). NPC43 serves as a vital model for investigating EBV-driven nasopharyngeal oncogenesis, viral latency/reactivation, tumor immunology, and therapeutic drug screening.

2. Biological Characteristics

  • Tissue Origin: Human Nasopharyngeal Carcinoma (NPC)

  • Growth Properties: Adherent, epithelial-like / polygonal morphology

  • EBV Status: EBV-positive

  • Cell Markers:

    • Epithelial markers: Cytokeratin (CK)

    • EBV-encoded gene products: EBNA1, LMP1, EBERs

  • Applications: EBV-associated NPC pathogenesis, EBV latency regulation, immunotherapeutic targeting, and radiosensitization drug discovery

3. Culture and Handling Protocols

Culture Medium Formulation

  • Basal Medium: RPMI-1640

  • Serum and Additives: 10 to 15 percent Fetal Bovine Serum (FBS), supplemented with ROCK inhibitor (Y-27632, 4 to 10 uM) as required for lineage maintenance

  • Antibiotics: 100 U/mL Penicillin and 100 ug/mL Streptomycin

Incubation and Subculture Guide

  • Incubation Conditions: 37 degrees Celsius, 5 percent CO2, humidified atmosphere

  • Confluence Management: Maintain cell density between 30 percent and 85 percent to prevent EBV loss or cell detachment

  • Subculture Procedure:

    1. Remove spent media and wash once with PBS.

    2. Add 0.25 percent Trypsin-EDTA and incubate at 37 degrees Celsius for 2 to 4 minutes until cells detach.

    3. Neutralize with complete medium and mix gently.

    4. Centrifuge at 200 x g for 5 minutes, resuspend, and seed at a ratio between 1:2 and 1:3.

4. Technical Data Summary

ParameterSpecification
Cell Line NameNPC43
Biosafety LevelBSL-2 (due to EBV presence)
EBV StatusEBV-Positive
Key MarkersCytokeratin, EBNA1, EBERs
MorphologyAdherent, epithelial-like
Primary UsesEBV-positive NPC research, viral latency targeted therapies, radio/chemosensitivity assays

BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

电话:400-800-2947

工作QQ/微信同号:1843439339

E-mail:BioVector@163.com

网址http://www.biovector.net


您正在向 biovector.net  发送关于产品 NPC43 BioVector® 人鼻咽癌细胞株 / NPC43 Human Nasopharyngeal Carcinoma Cell Line 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。